Colorectal cancer (CRC) is one of the leading causes of cancer-associated death glob- 
| INTRODUC TI ON
Colorectal cancer is the third most common malignancy and the fourth leading cause of death globally and about 1 400 000 new cases and 700 000 deaths occurred in 2012. 1 According to the data of Chinese National Cancer Center, CRC is the fourth most common cancer in women and the fifth in man, China suffered 376 300 new cases and 191 000 deaths of CRC in 2015. 2 Although researchers have made great efforts to elucidate the underlying tumourigenesis mechanism of the development of colorectal cancer, much of it is still unclear. Therefore, it is critical to explore the regulatory mechanisms of colorectal tumourigenesis to promote identification of promising diagnostic biomarkers as well as development of optimal therapeutic strategies.
Long non-coding RNAs (lncRNA) are recently discovered type of non-coding RNAs (ncRNA) with transcript more than 200 bp in length. 3 lncRNAs have been recognized to play important roles in tumourigenesis via regulating the expression of genes. Increasing number of evidence has illustrated that lncRNAs expression profiling may become useful tool for the diagnosis of cancers. 4, 5 Although a great amount of lncRNAs has been annotated, more efforts are needed to identify the function of them. 6 The hypothesis of competing endogenous RNA (ceRNA) described that by sharing miRNA response elements (MREs), lncRNAs and mRNAs compete for binding to miRNAs, which exert the role of regulating each other's expression 7 and affect the tumourigenesis and development of tumours. 8, 9 For the past few years, the widespread application of microarray and high throughput sequencing has greatly promoted the process of development of useful biomarkers for cancer diagnosis and management. Thanks to the publicly available cancer genomic databases, such as The Cancer Genome Atlas (TCGA), the comprehensive bioinformatics analysis has been employed in cancer research, which facilitates the discovery of a vast range of valuable biological information. Based on the ceRNA theory, researchers tried to construct lncRNA-miRNA-mRNA ceRNA networks in several kinds of malignance. [10] [11] [12] [13] [14] However, the data mining and analysis methods used in these reports were discrepant and the results were ambiguous and unconvincing. Out study first analysed the dysregulated expression of mRNA, lncRNA and miRNA between CRC tumour and normal tissues from TCGA database. Subsequently, the lncRNA-mediated ceRNA network was developed by bioinformatics prediction and correlation analysis. The RNAs functioning as prognostic biomarkers for patients with CRC were further identified by survival analysis. This study was conducted to investigate how the lncRNAs regulate target genes in the ceRNA regulatory network in CRC and predict novel lncRNAs as therapeutic targets and potential diagnostic biomarkers.
| MATERIAL S AND ME THODS

| Patients and TCGA data retrieval
By using the GDC Data Transfer Tool, the level 3 transcriptome sequencing data, miRNAseq data and corresponding clinical information of those patients were downloaded from TCGA database (up to August 23, 2018 (Table S1 ). Replicated cases and cases without complete transcriptome profiling data were excluded. The expression profiling was performed by Illumina HiSeq RNASeq and Illumina HiSeq_miR-NASeq platforms respectively. mRNAs and lncRNAs were identified and annotated by using the Ensembl database, 15 RNAs which were not annotated in the database were excluded. This study was performed following the TCGA publication guidelines. As the data were all retrieved from TCGA, approval from a local Ethics Committee were unnecessary.
| Identification of differentially expressed lncRNAs, mRNAs and miRNAs
The lncRNA, mRNA and miRNA expression data of tumour and normal samples were merged for COAD and READ respectively. Rows of RNA data with no expression or a mean count of ≤1 were deleted.
To obtain the differentially expressed lncRNAs, mRNAs and miRNAs between normal tissue and CRC, the count data were processed with the Bioconductor package edgeR 16 in R software. All RNA expression levels were standardized to the sample mean. The P value was corrected with a false discovery rate (FDR). Fold changes of expression levels (log2 absolute) ≥ 2 and FDR < 0.01 were considered as a statistically significant difference. Venn diagrams were made to select intersected RNAs that differentially expressed in both COAD and READ databases.
| Functional enrichment analysis
To elucidate potential biological processes and to explore promising signalling pathways associated with the differentially expressed mRNAs (DEmRNAs), we conducted the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and the gene ontology (GO) enrichment analysis using the Database for Annotation, Visualization and Integrated Discovery (DAVID, version 6.8). The biological processes and pathways with P < 0.05 were considered as significant functional categories.
| Development of a ceRNA network
The ceRNA network of CRC was then developed step-by-step according to the following procedures. Firstly, the file of potential interactions of lncRNA-miRNA was downloaded from StarBase V3.0 17 and miRcode. 18 StarBase provides the most comprehensive CLIPSeq experimentally supported miRNA-mRNA and miRNA-lncRNA interaction networks to date. About 10 000 ceRNA pairs from CLIP-supported miRNA target sites were identified in StarBase.
MiRcode provides 'whole transcriptome' human microRNA target predictions based on the comprehensive GENCODE gene annotation, including >10 000 long non-coding RNA genes. We filtered out the miRNAs that were not differentially expressed between tumour tissues and normal tissues. Next, three highly reliable online miRNA reference databases, miRTarBase, 19 miRDB, 20 and TargetScan,   21 were used to retrieve experimentally validated or predictive miRNA targeted mRNAs. To improve the reliability of prediction, only the mRNAs presented in all three databases were defined as the miRNAtargeted mRNAs. The targeted mRNAs were further compared with differentially expressed RNAs that identified between tumour tissues and normal tissues, the intersected mRNAs were retained to develop the ceRNA network. The ceRNA network was constructed and visualized by Cytoscape v3.6.1. 22 Figure 1 shows a flow chart for the development of the ceRNA network. For the lncRNAs, mRNAs and miRNAs included in the ceRNA network of CRC, we generated heat maps using the 'pheatmap' packages in the r software. Key lncRNA was identified by calculating the degree of edges between lncRNA nodes and first stage miRNA nodes in the network. The expanded secondary miRNA-mRNA interactomes were collected.
F I G U R E 1 Flow chart of comprehensive bioinformatics analysis in the construction of competing endogenous RNA (ceRNA) regulatory network
| Clinical samples
A total of 50 primary CRC tissues and adjacent normal tissues were collected from Department of Gastrointestinal Surgery, Beijing Hospital.
All tissues were frozen immediately in liquid nitrogen after surgical excision and stored at −80℃. Clinicopathological information was retrieved from the hospital database. Written informed consent was obtained from all patients and the study was approved by the ethics committee.
| Cell culture and transfection
Human colon epithelial cell line (NCM460) and colon cancer cell lines (HT29, SW480 and SW620) were obtained from American Type Culture Collection (ATCC, Manassas). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) in 5% CO 2 atmosphere at 37°C.
pcDNA3.1-ADAMTS9-AS2 and si-ADAMTS9-AS2 vectors were synthesized by Genechem (Shanghai, China) and then were transfected into CRC cells using Lipofectamine 3000 (Invitrogen).
| Quantitative real-time PCR
The expression levels of the key genes of the ceRNA regulatory 
| Survival and statistical analysis
Survival analyses for all RNAs in the ceRNA network were performed by using the 'survival' package in r software. Kaplan-Meier curve analysis with log-rank test was performed for comparison of the survival differences between groups. Co-expression analysis on the expression levels of RNAs was carried out by Pearson's correlation test. A P < 0.05 was considered statistically significant. Figure S1 ).
| RE SULTS
| Differentially expressed RNAs in CRC
| Gene ontology and pathway analysis of differentially expressed genes
To 
| Prognostic characteristics of RNAs in the regulatory network
Kaplan-Meier survival analysis was used to investigate the correlation between expression levels of DERNAs in the ceRNA network and the survival outcome of CRC patients. The results show that four lncRNAs (LINC00461, H19, C2orf48 and HOTAIR), six miRNAs (miR-145, miR-193b, miR-375, miR-144, miR-217 and miR-32) and five mRNAs (PHLPP2, CFL2, OSR1, TPM2 and HAND1) were significantly correlated with overall survival (P < 0.05) (Figure 4 ).
| Interaction between lncRNA and mRNA from the ceRNA Network
According to the ceRNA theory, lncRNAs could indirectly interact with mRNAs in the post-transcriptional regulatory network. To validate whether the network fit in with ceRNA theory, we conducted analysis on the correlation between expression levels of lncRNA and those of mRNAs. It showed that there was a strong positive correlation between expression levels of ceRNAs (Table S4 ). For instance, ADAMTS9-AS2 positively correlated with PHLPP2 (r = 0.758, P = 2.21e-112), FAM129A (r = 0.703, P = 3.32e-90), CHL1 (r = 0.682, P = 9.99e-83), CFL2 (r = 0.666, P = 1.14e-77), TCEAL7 (r = 0.658, P = 3.03e-75) and CYBRD1 (r = 0.612, P = 1.3e-62). In addition, hsamir-32 negatively interacted with lncRNA ADAMTS9-AS2 (r = -0.316, P = 3.57e-9) as well as PHLPP2 (r = −0.298, P = 3.32e-2) ( Figure 5 ).
| Experimental validation
The expression levels of ADAMTS9-AS2, miR-32 and PHLPP2 were Figure 6K) . Notably, the mRNA expression level of ADAMTS9 was significantly increased after ADAMTS9-AS2 knockdown and decreased after ADAMTS9-AS2 overexpression ( Figure 6L ).
| D ISCUSS I ON
As shown in the present study, differentially expressed mRNAs, lncRNAs and miRNAs were identified in tumour samples compared with adjacent non-tumour samples from TCGA-COAD and READ Among the ceRNA network, the lncRNA ADAMTS9-AS2 is the most notable gene because it has the highest degree of connectivity to other nodes, although its relationship with survival was not significant, we assumed that it was a hub gene that plays critical roles in the network. Then we extracted a sub-network that centred on ADAMTS9-AS2 for further analysis. The results showed that ADAMTS9-AS2 directly interacted with 13 miRNAs and indirectly interacted with 21 miRNA-targeted mRNAs in this network ( Figure 3B ).
By investigating the sub-network, we found that overexpression of three miRNAs (hsa-mir-32, hsa-mir-217 and hsa-mir-144) was associated with unfavourable prognosis. Further analysis indicated that there was an interaction between hsa-mir-32 and mRNA PHLPP2. To summary, a ceRNA regulatory network was successfully developed by identification of cancer-specific lncRNAs, miRNAs and mRNAs from large-scale CRC samples in TCGA database. We propose that the regulatory network centred on ADAMTS9-AS2 may play a critical part in the carcinogenesis of CRC. Our study highlighted a novel ceRNA mechanism in which ADAMTS9-AS2 sponging miR-32 to regulate the expression of PHLPP2. However, the ADAMTS9-AS2/miR-32/ PHLPP2 regulatory axis requires further studies to fully elucidate their biological functions and to confirm the molecular mechanisms.
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TA B L E 1 Correlation between ADAMTS-AS2, miR-32 and PHLPP2 mRNA expression levels and the clinicopathological parameters of 50 CRC patients Abbreviations: CEA carcinoembryonic antigen; TNM tumour-node-metastasis stage. *P < 0.05; **P < 0.01.
